Essex Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-112,934
Closed -$3.11M 335
2023
Q4
$3.11M Sell
112,934
-62,815
-36% -$1.52M 0.61% 50
2023
Q3
$3.92M Sell
175,749
-12,168
-6% -$313K 0.64% 41
2023
Q2
$4.79M Buy
187,917
+14,200
+8% +$344K 0.67% 38
2023
Q1
$3.87M Buy
173,717
+34,155
+24% +$826K 0.56% 48
2022
Q4
$3.31M Sell
139,562
-4,296
-3% -$99.8K 0.52% 60
2022
Q3
$2.39M Buy
143,858
+1,914
+1% +$43.1K 0.38% 79
2022
Q2
$2.83M Sell
141,944
-79,717
-36% -$1.61M 0.46% 65
2022
Q1
$6.11M Buy
221,661
+61,872
+39% +$1.77M 0.76% 33
2021
Q4
$6.58M Buy
159,789
+34,023
+27% +$1.5M 0.75% 33
2021
Q3
$5.84M Sell
125,766
-1,245
-1% -$54.3K 0.72% 34
2021
Q2
$5.08M Buy
127,011
+9,948
+8% +$425K 0.59% 45
2021
Q1
$6.29M Buy
117,063
+6,353
+6% +$366K 0.77% 29
2020
Q4
$5.42M Buy
110,710
+29,128
+36% +$1.35M 0.67% 30
2020
Q3
$2.65M Buy
81,582
+2,726
+3% +$86.6K 0.38% 71
2020
Q2
$2.04M Sell
78,856
-36,239
-31% -$903K 0.33% 86
2020
Q1
$2.8M Sell
115,095
-17,334
-13% -$436K 0.57% 41
2019
Q4
$3.7M Sell
132,429
-81,623
-38% -$2.11M 0.45% 56
2019
Q3
$5.14M Sell
214,052
-24,373
-10% -$648K 0.74% 25
2019
Q2
$6.8M Sell
238,425
-73,389
-24% -$1.83M 0.93% 17
2019
Q1
$7.8M Sell
311,814
-7,922
-2% -$151K 1.15% 13
2018
Q4
$4.02M Buy
319,736
+4,450
+1% +$52.6K 0.63% 33
2018
Q3
$3.01M Buy
315,286
+10,531
+3% +$116K 0.35% 77
2018
Q2
$2.85M Buy
304,755
+65,529
+27% +$461K 0.36% 86
2018
Q1
$1.33M Sell
239,226
-13,243
-5% -$81.9K 0.17% 168
2017
Q4
$1.65M Buy
252,469
+68,265
+37% +$508K 0.22% 150
2017
Q3
$1.61M Buy
+184,204
New +$1.5M 0.22% 155

Other funds holding VCYT

Essex Investment Management's VCYT Position: Q1 2024 in Review

Essex Investment Management sold out of Veracyte (VCYT) in Q1 2024, closing a stake of 112,934 shares — an estimated $3.11M sold.

Essex Investment Management first reported a position in VCYT in Q3 2017 and held it in 26 quarters. The position peaked at $7.8M in Q1 2019. 246 funds tracked by Wall St. Rank hold VCYT as of Q1 2024.

  • Essex Investment Management reported no remaining Veracyte position as of Q1 2024 after selling out during the quarter.
  • Essex Investment Management sold 112,934 Veracyte shares in Q1 2024, an estimated $3.11M.
  • Essex Investment Management first reported a position in Veracyte in Q3 2017 and held it in 26 quarters.
  • Essex Investment Management's Veracyte position peaked at $7.8M in Q1 2019.
  • 246 funds tracked by Wall St. Rank held Veracyte as of Q1 2024.

Based on Essex Investment Management's 13F filing for Q1 2024, filed 3 May 2024.